CD274 and hepatocellular carcinoma: Furthermore, a combination of the presence of deletion mutations spanning the pre-S2 gene segment and high densities of PD-L1-expressing cells and Tregs was validated as an independent prognostic biomarker with better performance in predicting a higher risk of post-operative HCC recurrence than that of either one or a combination of either two of these three biomarkers.